Regeneron Study Site — Boston, Massachusetts

Regeneron Study Site is a clinical research site located in Boston, Massachusetts, United States 02111.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Regeneron Study Site has participated in 26 clinical trials.

Therapeutic areas: Atopic Dermatitis, Conjunctivitis, Eosinophilic Esophagitis (EoE).

Sponsors: Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Regeneron Study Site?

Regeneron Study Site has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Regeneron Study Site conducted?

Regeneron Study Site has 26 clinical trials on record. Their work covers Atopic Dermatitis, Conjunctivitis, Eosinophilic Esophagitis (EoE).

Is Regeneron Study Site accredited by Crixeo Health?

Yes — Regeneron Study Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Regeneron Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.